239 related articles for article (PubMed ID: 20537953)
1. Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies.
Georgel P; Schuster C; Zeisel MB; Stoll-Keller F; Berg T; Bahram S; Baumert TF
Trends Mol Med; 2010 Jun; 16(6):277-86. PubMed ID: 20537953
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus entry.
Zeisel MB; Felmlee DJ; Baumert TF
Curr Top Microbiol Immunol; 2013; 369():87-112. PubMed ID: 23463198
[TBL] [Abstract][Full Text] [Related]
3. Priming of Antiviral CD8 T Cells without Effector Function by a Persistently Replicating Hepatitis C-Like Virus.
Hartlage AS; Walker CM; Kapoor A
J Virol; 2020 May; 94(10):. PubMed ID: 32102885
[TBL] [Abstract][Full Text] [Related]
4. Innate and adaptive immune responses in HCV infections.
Heim MH; Thimme R
J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
[TBL] [Abstract][Full Text] [Related]
5. High-throughput approaches to unravel hepatitis C virus-host interactions.
Colpitts CC; El-Saghire H; Pochet N; Schuster C; Baumert TF
Virus Res; 2016 Jun; 218():18-24. PubMed ID: 26410623
[TBL] [Abstract][Full Text] [Related]
6. A Hepatitis C virus-host interaction involved in viral replication: toward the identification of antiviral targets.
Suzuki T
Jpn J Infect Dis; 2010 Sep; 63(5):307-11. PubMed ID: 20858994
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies.
Zeisel MB; Fofana I; Fafi-Kremer S; Baumert TF
J Hepatol; 2011 Mar; 54(3):566-76. PubMed ID: 21146244
[TBL] [Abstract][Full Text] [Related]
8. Steps and Routes of HCV Infection: The Great Promise of New Anti-Viral Targets.
Crema A; Ponzetto A; Clementi M; Carloni G
Curr Drug Targets; 2015; 16(7):757-70. PubMed ID: 25694122
[TBL] [Abstract][Full Text] [Related]
9. Immunometabolic Effect of Cholesterol in Hepatitis C Infection: Implications in Clinical Management and Antiviral Therapy.
González-Aldaco K; Torres-Reyes LA; Ojeda-Granados C; José-Ábrego A; Fierro NA; Román S
Ann Hepatol; 2018 Oct; 17(6):908-919. PubMed ID: 30600305
[TBL] [Abstract][Full Text] [Related]
10. Activation and evasion of antiviral innate immunity by hepatitis C virus.
Horner SM
J Mol Biol; 2014 Mar; 426(6):1198-209. PubMed ID: 24184198
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C Virus.
Pietschmann T; Brown RJP
Trends Microbiol; 2019 Apr; 27(4):379-380. PubMed ID: 30709707
[TBL] [Abstract][Full Text] [Related]
12. The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses.
Shin EC; Han JW; Kang W; Kato T; Kim SJ; Zhong J; Kim S; Park SH; Sung PS; Watashi K; Park JY; Windisch MP; Oh JW; Wakita T; Han KH; Jang SK
Viruses; 2020 Mar; 12(3):. PubMed ID: 32168867
[No Abstract] [Full Text] [Related]
13. Development of novel treatments for hepatitis C.
Webster DP; Klenerman P; Collier J; Jeffery KJ
Lancet Infect Dis; 2009 Feb; 9(2):108-17. PubMed ID: 19179226
[TBL] [Abstract][Full Text] [Related]
14. N-Myc Downstream-Regulated Gene 1 Restricts Hepatitis C Virus Propagation by Regulating Lipid Droplet Biogenesis and Viral Assembly.
Schweitzer CJ; Zhang F; Boyer A; Valdez K; Cam M; Liang TJ
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118118
[TBL] [Abstract][Full Text] [Related]
15. Treating hepatitis C infection by targeting the host.
Salloum S; Tai AW
Transl Res; 2012 Jun; 159(6):421-9. PubMed ID: 22633094
[TBL] [Abstract][Full Text] [Related]
16. Therapy Implications of Hepatitis C Virus Genetic Diversity.
Martinez MA; Franco S
Viruses; 2020 Dec; 13(1):. PubMed ID: 33383891
[TBL] [Abstract][Full Text] [Related]
17. Innate and Adaptive Immune Responses in Chronic HCV Infection.
Dustin LB
Curr Drug Targets; 2017; 18(7):826-843. PubMed ID: 26302811
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy.
Dustin LB; Bartolini B; Capobianchi MR; Pistello M
Clin Microbiol Infect; 2016 Oct; 22(10):826-832. PubMed ID: 27592089
[TBL] [Abstract][Full Text] [Related]
19. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
[TBL] [Abstract][Full Text] [Related]
20. HCV-hepatocellular carcinoma: new findings and hope for effective treatment.
Dash S; Haque S; Joshi V; Prabhu R; Hazari S; Fermin C; Garry R
Microsc Res Tech; 2005 Nov; 68(3-4):130-48. PubMed ID: 16276514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
